A director at Arab Co. For Asset Management And Development bought/sold 6,250,000 shares at 0.000EGP and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
A director at Valmore Holding sold/bought 100,000 shares at 0.000USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
A director at Techno Medica Co Ltd sold 300,000 shares at 2,249.000JPY and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Moody's Ratings ("Moody's") has affirmed the B2 Corporate Family Rating (CFR) and the B2-PD Probability of Default Rating (PDR) for ARC Falcon I Inc. ("Arclin"). We have also assigned a B2 rating to the company's new seven year $1.225 billion senior secured first lien term loan, new seven year $1.5 ...
Sale of a subsidiary of EfTEN Real Estate Fund AS in Latvia EfTEN Real Estate Fund AS is selling the DSV logistics property in Riga at 500 thousands euros above the balance sheet value. The transaction is structured as a share deal selling the 100% subsidiary EfTEN Krustpils SIA (registration number with the Latvian Commercial Register 40103921371), for which the fund has entered into a sale and purchase agreement with the Latvian company ROLANDS S, SIA (registration number with the Latvian Commercial Register 40103130964). The activities of EfTEN Krustpils SIA are related to the ownership ...
Hexagon Purus ASA: Results for the fourth quarter 2025 Key developments in Q4 2025 and after balance sheet date: Revenue of NOK 468 million in the fourth quarter of 2025, 18% higher compared to same period last year. FY 2025 revenue was NOK 1,144 million, down 39% compared to FY 2024;EBITDA of NOK -99 million (-21% margin) in the fourth quarter of 2025, compared to NOK -104 million (-26% margin) in the same period last year. EBITDA in the fourth quarter of 2025 included NOK 76 million of inventory write-downs, warranty provisions, bad debt expense and restructuring costs (“Items Affecting ...
Unaudited financial results of LHV Group for Q4 and 12 months of 2025 At the end of 2025, LHV Group’s deposit and loan portfolio volumes both demonstrated very strong growth. In 2025, LHV Group’s revenue dynamics were influenced by changes in the interest rate environment throughout the year, which put pressure on interest income, while strong competition in the deposit market increased interest expenses. Strong growth in customer activity and fee and commission income helped to partially offset the decline in net interest income. In Q4, net interest income already showed growth compared to...
TGS announces Engagement Phase 9 in the Gulf of America OSLO, Norway (10 February 2026) – TGS, a global provider of energy data and intelligence, in strategic collaboration with SLB, today announced the launch of Engagement 9, the latest phase of the companies’ Ocean Bottom Node (OBN) multi-client campaign in the Gulf of America. Commencing earlier this month, Engagement 9 covers 161 OCS blocks in the Walker Ridge protraction area, one of the Gulf of America’s most prolific deepwater provinces. This new dataset is expected to deliver step change improvements in subsurface illumination acro...
EfTEN Real Estate Fund AS-i tütarettevõtte müük Lätis EfTEN Real Estate Fund AS müüb DSV logistikahoone Riias bilansilisest väärtusest ligakaudu 500 tuhande euro võrra kõrgema hinnaga. Tehing on struktureeritud tütarettevõtte EfTEN Krustpils SIA (registreerimisnumber Läti ettevõtteregistris 40103921371) 100%-lise osaluse müügina, milleks on fond sõlminud võlaõigusliku müügilepingu Läti ettevõtte ROLANDS S, SIA-ga (registreerimisnumber Läti ettevõtteregistris 40103130964). EfTEN Krustpils SIA tegevus on seotud Riias Krustpils 31 asuva kinnistu (DSV logistikahoone) omamise ja majandamisega. T...
LHV Groupi 2025. aasta IV kvartali ja 12 kuu auditeerimata majandustulemused 2025. aasta lõpus näitasid LHV Groupi deposiitide kui ka laenuportfelli mahud väga tugevat kasvu. 2025. aastal mõjutas LHV Groupi tulude dünaamikat kogu aasta väldanud intressikeskkonna muutus, mis avaldas survet intressituludele ning teiselt poolt survestas intressikulusid tugev konkurents hoiuste turul. Hea kliendiaktiivsuse kasv ja teenustasutulu aitasid neto intressitulu langust osaliselt tasakaalustada. IV kvartalis oli näha juba neto intressitulu kasvu võrreldes eelnevate kvartalitega. AS LHV Group teenis 20...
WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd (“WISeKey” or the “Company”) (SIX: WIHN, Nasdaq: WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. (“WISeSat”) specialized...
Santhera Appoints Stifel as Corporate Finance Advisor Pratteln, Switzerland, February 10, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced the appointment of Stifel Nicolaus Europe Limited (“Stifel”) as corporate finance advisor with a focus on capital markets and international institutional investors. Swiss based Octavian AG (“Octavian”) will continue to act as corporate finance advisor to the Company, working alongside Stifel to help broaden investor reach. About SantheraSanthera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the developmen...
Wereldhave Full-year results 2025 Direct result 2025 at € 1.86 per share, above guidance of € 1.80-1.85Occupancy rate at 98%, highest since 2013Like-for-like rental growth of +6%, driven by improved Dutch retail market and focus on other incomeDisposal of Dutch FSC Sterrenburg (€ 60m) at book value in December 2025Stable cost base despite portfolio growth and inflationTotal shareholder return 2025 of +51%Proposed dividend for 2025 at € 1.30 per share (+4%)Outlook 2026 direct result per share € 1.85-1.95 Attachment
Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day Amsterdam, February 10, 2026Full year and Q4 highlights Comparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in 2025, EUR 5.1 billion in Q4; comparable sales growth 2% in 2025, 7% in Q4Income from operations was EUR 1,424 million in 2025; EUR 540 million in Q4Adjusted EBITA margin increased 80 basis points to 12.3% of sales in 2025; up 160 basis points to 15.1% in Q4Operating cash flow of EUR 1,172 million...
Kering - 2025 results: Sequential improvement, unlocking the next phase of sustainable & profitable growth PRESS RELEASEFebruary 10, 2026 2025 RESULTS: SEQUENTIAL IMPROVEMENT, UNLOCKING THE NEXT PHASE OF SUSTAINABLE & PROFITABLE GROWTH Strengthened balance sheet providing strategic flexibility 2026 outlook: return to growth and margin improvement Capital Markets Day: Kering roadmap to build a leaner, faster Group, focused on enhancing brand desirability to reignite growth Revenue: €14,675 milliondown 13% as reported and 10% on a comparable basiswith Q4 revenue down 9% as reported...
Kering - Résultats 2025 : amélioration séquentielle, cap sur une nouvelle phase de croissance durable et profitable COMMUNIQUÉ DE PRESSE 10 février 2026 RÉSULTATS 2025 : AMÉLIORATION SÉQUENTIELLE, CAP SUR UNE NOUVELLE PHASE DE CROISSANCE DURABLE ET PROFITABLE Un bilan renforcé, qui offre une plus grande flexibilité stratégique Perspectives 2026 : retour à la croissance et amélioration des marges Capital Markets Day : la feuille de route de Kering pour bâtir un Groupe plus agile, plus rapide et déterminé à renforcer la désirabilité de ses Maisons...
AB InBev is due to report its full year results on 12 February. We have adjusted our forecasts for the fourth quarter to account for weaker than previously expected volumes in North America, Brazil and China. We have also increased our 12-month target price from €56.18 to €66.20 but change our recommendation from Buy to HOLD.
Santhera ernennt Stifel zum Finanzberater Pratteln, Schweiz, 10. Februar 2026 – Santhera Pharmaceuticals (SIX: SANN) gab heute die Ernennung von Stifel Nicolaus Europe Limited (“Stifel”) zum Finanzberater mit Schwerpunkt auf Kapitalmärkten und internationalen institutionellen Anlegern bekannt. Die in der Schweiz ansässige Octavian AG (“Octavian”) wird weiterhin als Corporate-Finance-Berater des Unternehmens fungieren und gemeinsam mit Stifel daran arbeiten, den Kreis der Investoren zu erweitern. Über SantheraSanthera Pharmaceuticals (SIX: SANN) ist ein Schweizer Spezialpharmaunternehmen, ...
We raise our target price for Fagron from €25.5 to €27.0 ahead of its FY25 results on 12 February. We reiterate our BUY recommendation as the shares continue to offer a compelling combination of organic growth (2018-25F CAGR 8%, 2025-30F target HSD% to LDD%) and active and accretive M&A, in our view.
Philips proposes to re-appoint CEO Roy Jakobs February 10, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board’s recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming An...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.